Paper3494555
Cloned human cytotoxic T lymphocytes develop anomalous killer cell function.
Burns GF and 2 others. Clin Exp Immunol, 1986. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Cloned human cytotoxic T lymphocytes develop anomalous killer cell function. Papers, record 3494555. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3494555
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Killer Cells, Natural | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Antigens | |
| B-Lymphocytes | |
| Binding, Competitive | |
| Cell Transformation, Viral | |
| Clone Cells | |
| Cytotoxicity, Immunologic | |
| Humans | |
| Interleukin-2 | |
| Melanoma, Experimental |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6194213 | Blockade of NK cell lysis is a property of monoclonal antibodies that bind to distinct regions of T-200. | J Immunol | 1983 | https://conductscience.org/library/papers/6194213 | PubMed |
| 2 | 6192076 | Lymphokine-driven "differentiation" of cytotoxic T-cell clones into cells with NK-like specificity: correlations with display of membrane macromolecules. | Immunol Rev | 1983 | https://conductscience.org/library/papers/6192076 | PubMed |
| 3 | 6197466 | Loss of specificity in cytolytic T lymphocyte clones obtained by limit dilution culture of Ly-2+ T cells. | J Immunol | 1984 | https://conductscience.org/library/papers/6197466 | PubMed |
| 4 | 6608725 | Human natural killer cells, activated lymphocyte killer cells, and monocytes possess similar cytotoxic mechanisms. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6608725 | PubMed |
| 5 | 6204000 | A cloned human T cell line cytotoxic for autologous and allogeneic B lymphoma cells. | J Exp Med | 1984 | https://conductscience.org/library/papers/6204000 | PubMed |
| 6 | 6205072 | Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies. | J Immunol | 1984 | https://conductscience.org/library/papers/6205072 | PubMed |
| 7 | 6236274 | Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid. | J Exp Med | 1984 | https://conductscience.org/library/papers/6236274 | PubMed |
| 8 | 6679886 | Clonal expansion of human B73.1-positive natural killer cells or large granular lymphocytes exerting strong antibody-dependent and -independent cytotoxicity and occasionally lectin-dependent cytotoxicity. | Nat Immun Cell Growth Regul | 1983 | https://conductscience.org/library/papers/6679886 | PubMed |
| 9 | 2580933 | TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors. | J Exp Med | 1985 | https://conductscience.org/library/papers/2580933 | PubMed |
| 10 | 3158401 | In vitro generation of human activated lymphocyte killer cells. II. N-acetyl-D-galactosamine inhibits a distinct subpopulation of human activated lymphocyte killer cells generated in mixed lymphocyte culture. | Cell Immunol | 1985 | https://conductscience.org/library/papers/3158401 | PubMed |
| 11 | 3889158 | The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo. | J Immunol | 1985 | https://conductscience.org/library/papers/3889158 | PubMed |
| 12 | 3873498 | Identification of a structure on human melanoma cells recognized by CTL exhibiting anomalous killer cell function. | J Immunol | 1985 | https://conductscience.org/library/papers/3873498 | PubMed |
| 13 | 2412835 | Degradation of specificity in cytolytic T lymphocyte clones: two broad specificity, H-2-independent recognition systems, one natural killer-like, develop during culture, in addition to the clonally distributed antigen-specific receptor. | Eur J Immunol | 1985 | https://conductscience.org/library/papers/2412835 | PubMed |
| 14 | 3903508 | Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. | N Engl J Med | 1985 | https://conductscience.org/library/papers/3903508 | PubMed |
| 15 | 6803172 | A differentiation factor required for the expression of cytotoxic T-cell function. | Nature | 1982 | https://conductscience.org/library/papers/6803172 | PubMed |
| 16 | 6978927 | Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses. | J Exp Med | 1982 | https://conductscience.org/library/papers/6978927 | PubMed |
| 17 | 6980937 | Two monoclonal anti-human T lymphocyte antibodies have similar biologic effects and recognize the same cell surface antigen. | J Immunol | 1982 | https://conductscience.org/library/papers/6980937 | PubMed |
| 18 | 6600253 | Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2. | J Immunol | 1983 | https://conductscience.org/library/papers/6600253 | PubMed |
| 19 | 6220056 | Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures. | J Immunol | 1983 | https://conductscience.org/library/papers/6220056 | PubMed |
| 20 | 6300247 | In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells. | J Immunol | 1983 | https://conductscience.org/library/papers/6300247 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 2451830 | Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/2451830 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ITGAL | 3683 | PubTator's text mining | https://conductscience.org/library/genes/3683 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3494555
GET https://conductscience.org/api/papers/v1/3494555/references?page=2